These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5299262)

  • 1. [On the evidence of antinuclear factors in various forms fof psoriasis].
    Sönnichsen N; Apostologg G
    Arch Klin Exp Dermatol; 1966; 227(1):247-9. PubMed ID: 5299262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear factors in psoriasis vulgaris. (Preliminary report)].
    Sönnichsen N; Apostoloff G; Nebe H
    Dermatol Wochenschr; 1965 Dec; 151(51):1423-5. PubMed ID: 5296268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antinuclear factors in psoriasis vulgaris and psoriasis arthropathica?].
    Meyer zum Büschenfelde
    Arch Klin Exp Dermatol; 1968; 233(1):59-62. PubMed ID: 4177789
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the problem of immunologic demonstration of antinuclear factors in arthropathic psoriasis].
    Barthelmes H; Sönnichsen N; Kluge K
    Dermatol Wochenschr; 1968 Aug; 154(35):817-21. PubMed ID: 4880882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic and clinical studies on psoriasis].
    Sönnichsen N; Apostoloff G; Apostoloff E; Krell L
    Dtsch Gesundheitsw; 1966 May; 21(21):973-8. PubMed ID: 5298519
    [No Abstract]   [Full Text] [Related]  

  • 6. Antinuclear autoantibodies in flaky skin (fsn) mutant mice.
    Withington S; Maltby-Askari E; Welner R; Parker R; Pelsue SC
    Autoimmunity; 2002 May; 35(3):175-81. PubMed ID: 12389642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.
    Rodríguez-Jiménez P; Chicharro P; Godoy A; Llamas-Velasco M; García M; Daudén E
    Br J Dermatol; 2017 Sep; 177(3):862-863. PubMed ID: 28508387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin levels and tissue antibodies in psoriasis.
    Lin RY; Deng JS; Lu YC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Jun; 11(2):45-9. PubMed ID: 310380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANA titers in lupus erythematosus and certain chronic dermatoses.
    Carnabuci GJ; Luscombe HA; Stoloff IL
    Arch Dermatol; 1967 Mar; 95(3):247-9. PubMed ID: 5340593
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathology of psoriasis.
    Cormane RH
    Arch Dermatol Res; 1981; 270(2):201-15. PubMed ID: 6264864
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study.
    Saraceno R; Specchio F; Torres T; Nisticò SP; Rizza S; Chimenti S
    J Am Acad Dermatol; 2012 May; 66(5):e180-2. PubMed ID: 22507590
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction.
    Hoffmann JH; Hartmann M; Enk AH; Hadaschik EN
    Br J Dermatol; 2011 Dec; 165(6):1355-8. PubMed ID: 21801160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the unpredictable: autoantibody profile as parameter to foretell individual responses to infliximab treatment?
    Schön MP
    Br J Dermatol; 2011 Dec; 165(6):1160-1. PubMed ID: 22118556
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rheumatoid factor and antinuclear factors in psoriasis arthropathica and other forms of psoriasis].
    Beickert A; Hering H
    Dtsch Gesundheitsw; 1968 Dec; 23(51):2408-13. PubMed ID: 4180258
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.
    Rosenberg JN; Johnson GD; Holborow EJ
    Ann Rheum Dis; 1979 Dec; 38(6):526-8. PubMed ID: 317236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor Inhibitors, Antinuclear Antibodies, and Autoimmunity in Patients With Psoriasis.
    de la Cueva Dobao P
    Actas Dermosifiliogr; 2017 Jun; 108(5):393-394. PubMed ID: 28335984
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune mechanisms in psoriasis.
    Reeves WH
    Semin Dermatol; 1991 Sep; 10(3):217-24. PubMed ID: 1931571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear factor in rheumatoid arthritis and related diseases.
    Pitkeathly DA; Taylor G
    Ann Rheum Dis; 1967 Jan; 26(1):1-9. PubMed ID: 4163368
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis but do not necessarily predict treatment failure.
    Golberg O; Osborne JE; Hutchinson PE
    Br J Dermatol; 2011 Feb; 164(2):459-60. PubMed ID: 20973773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.